Epstein Secrets

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

inancial Analysis ALIPHCOM - COMMON EQUITY VALUATION As of June 20, 2011 10 EFTA00307405 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of JUlle 20, 2011 Exhibit B: Historical Financial Analysis Aliph's revenues rebounded in 2010 following the decline in 2009 as a result of the lackluster de

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

inancial Analysis ALIPHCOM - COMMON EQUITY VALUATION As of June 20, 2011 10 EFTA00307304 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of JUlle 20, 2011 Exhibit B: Historical Financial Analysis Aliph's revenues rebounded in 2010 following the decline in 2009 as a result of the lackluster de

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

inancial Analysis ALIPHCOM - COMMON EQUITY VALUATION As of June 20, 2011 10 EFTA00307203 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of JUlle 20, 2011 Exhibit B: Historical Financial Analysis Aliph's revenues rebounded in 2010 following the decline in 2009 as a result of the lackluster de